Vitamin B 12 deficiency and atherosclerotic vascular disease Hyperhomocysteinaemia, as an independent risk factor for cardiovascular disease, has been receiving increased attention
Starting at too-high a frequency can trigger a temporary rough-texture phase (sometimes called the copper peptide uglies) caused by MMP activity briefly outpacing new collagen synthesis
thx for sharing I see this clinically very relevant and interesting We see this clinically - thank you for sharing This is good news - thank you for sharing!
Yes, but be mindful of interactions
Aromatase inhibitors, a common class of breast cancer medication, seem to limit the effectiveness of GLP-1 drugs, perhaps due to their anti-estrogen effects
RECOVERs 2nd Round of Long COVID Clinical Trials Shows Progress and Limitations by Cort Johnson | Oct 10, 2025 | Baricitinib, GLP-1, GLP-1 agonist, Homepage, Low Dose Naltrexone, NIH, Stellate Ganglion Block, Treatment The RECOVER Initiative announces four more clinical trials for long COVID including low dose naltrexone, bariticinib, GLP-1 agonists, and stellate ganglion blockade.
